Incyte Corp. Should Move Higher (Technical Analysis)

Walter Zelezniak Jr profile picture
Walter Zelezniak Jr
3.25K Followers

Summary

  • Incyte is outperforming the SP 500.
  • Institutions are accumulating shares.
  • My price target on INCY is $100.

bull and chart for business or bull market trader concept

niphon

Incyte Corp. is Moving Higher

Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that is outperforming the SP 500 index. There are several bullish indications why INCY could reach $100. In this article, I will outline why I am looking to add to

INCY Stock Price Chart

www.stockcharts.com

INCY Weekly Chart

www.stockcharts.com

INCY Daily Chart

www.stockcharts.com

This article was written by

Walter Zelezniak Jr profile picture
3.25K Followers
As an individual investor nearing retirement I am trying to build my financial assets in order to have a fulfilling retirement. I am interested in trading both long and short; or at least using inverse ETFs, to take advantage of market declines. Having long term and short term trading strategies, proper execution of my trading plan, and absolute investing results are my goals. I see my articles as a way to keep me focused on developing winning trades. I also expect to learn much from the feedback that is provided in the comments section.

Disclosure: I/we have a beneficial long position in the shares of INCY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: I hold INCY shares and I am looking to add to my position above $80.40.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.